Advagene Biopharma Co. Ltd.
7 clinical trials · Sponsor
◉ Watch Advagene Biopharma Co. Ltd.
| Record | Firm | Date |
|---|---|---|
| A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma (NCT07250594) | Advagene Biopharma Co. Ltd. | 2025-12-01 |
| Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19 (NCT05541510) | Advagene Biopharma Co. Ltd. | 2022-12-01 |
| Evaluating Safety, Tolerability, and Potential Efficacy of Intranasal AD17002 in Adults With Mild to Moderate COVID-19 (NCT05069610) | Advagene Biopharma Co. Ltd. | 2022-03-21 |
| Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis (NCT04088721) | Advagene Biopharma Co. Ltd. | 2019-03-26 |
Track Advagene Biopharma Co. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.